Financials in GBp. Standardized financial statements.
A compact view of how The Biotech Growth Trust PLC turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £137.16M | -£77.48M | £80.35M | -£37.65M | -£209.71M | £204.35M | £63.89M | £23.05M | -£27.51M | £100.47M |
| Revenue Growth? | +277.0% | -196.4% | +313.4% | +82.0% | -202.6% | +219.8% | +177.2% | +183.8% | -127.4% | 0.0% |
| Cost of Revenue? | £4.64M | £1.32M | £2.35M | £5.31M | £4.80M | -£17.76M | -£5.04M | -£6.00M | £4.35M | £4.03M |
| Gross Profit? | £132.52M | -£78.81M | £78.00M | -£42.97M | -£214.51M | £222.11M | £68.94M | £29.04M | -£31.86M | £96.44M |
| Gross Margin? | +96.6% | +101.7% | +97.1% | +114.1% | +102.3% | +108.7% | +107.9% | +126.0% | +115.8% | +96.0% |
| Operating Expenses? | £629,000 | £3.71M | £3.24M | £3.59M | -£7.44M | £3.80M | £2.80M | £1.76M | £2.03M | £1.89M |
| Operating Income? | £131.89M | -£82.52M | £76.50M | -£36.69M | -£199.75M | £197.34M | £64.66M | £24.49M | -£29.05M | £98.86M |
| EBITDA? | £131.43M | -£82.52M | £0 | £0 | -£10.73M | £0 | £0 | -£3.20M | £2.39M | -£280,000 |
| Income Before Tax | £130.29M | -£82.52M | £74.76M | -£41.24M | -£202.27M | £200.56M | £61.09M | £21.29M | -£29.54M | £98.58M |
| Income Tax Expense | £32,000 | £145,000 | £159,000 | £56,000 | £149,000 | £131,000 | £196,000 | £186,000 | £238,000 | £281,000 |
| Net Income? | £130.25M | -£82.66M | £74.60M | -£41.30M | -£202.42M | £200.43M | £60.90M | £21.10M | -£29.78M | £98.30M |
| EPS? | £5.58 | £-2.62 | £2.07 | £-1.03 | £-4.88 | £5.01 | £1.35 | £0.39 | £-0.53 | £1.72 |
| Diluted EPS? | £5.58 | £-2.62 | £2.07 | £-1.03 | £-4.88 | £5.01 | £1.35 | £0.39 | £-0.53 | £1.72 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality